Indian healthtech startup CURAPOD has raised Rs 20 crore (approximately $2.2 million) in a pre-Series A funding round led by V3 Ventures, 3i Partners, and Ideaspring Capital. The company is also backed by Litemed, strengthening its position in the rapidly growing wearable healthcare and pain management segment.
The fresh infusion of capital marks a significant milestone for CURAPOD as it looks to scale its operations, deepen product innovation, and expand its market presence across India.
Funding to Accelerate R&D and Product Innovation
CURAPOD plans to utilize the newly raised funds to accelerate research and development, with a strong focus on enhancing both its wearable pain management device and its companion mobile application. By investing in advanced R&D, the startup aims to improve treatment personalization, user experience, and clinical outcomes for patients suffering from musculoskeletal conditions.
In addition to product development, the company will also scale its manufacturing capabilities to meet growing demand and ensure consistent product quality as adoption increases.
Strengthening Go-To-Market and D2C Presence
A key part of CURAPOD’s growth strategy involves expanding its go-to-market initiatives. The startup plans to strengthen its direct-to-consumer (D2C) channel, making its devices more accessible to individuals seeking non-invasive and drug-free pain relief solutions.
CURAPOD is also looking to expand strategic partnerships with gyms, physiotherapy centers, and sports medicine networks. These collaborations will help the brand reach patients at critical touchpoints where musculoskeletal pain and sports-related injuries are most commonly addressed.
At the same time, the company aims to improve operational efficiencies to support sustainable growth and optimize customer service and fulfillment processes.
Founded to Address Musculoskeletal Pain Without Drugs
Founded in 2022 by Sri Velliyur and Surya Maguluri, CURAPOD was created with the mission of transforming how musculoskeletal pain is managed. The startup develops wearable, non-invasive pain management devices designed for individuals dealing with chronic and acute musculoskeletal issues.
CURAPOD’s solution is particularly focused on conditions such as back pain, neck pain, knee pain, joint disorders, muscle stiffness, and sports-related injuries—ailments that affect millions of people and often lead to long-term dependence on medication.
Powered by Photobiomodulation Therapy
At the core of CURAPOD’s technology is photobiomodulation therapy, a clinically studied approach that uses specific wavelengths of light to reduce pain, inflammation, and muscle stiffness. The device delivers targeted therapy directly to the affected area, offering relief without the side effects commonly associated with painkillers or invasive procedures.
The CURAPOD device is FDA-registered and supports treatment for more than 30 musculoskeletal conditions, making it a versatile and credible option for both patients and healthcare professionals.
Clinician-Led Adoption and Nationwide Expansion
CURAPOD follows a clinician-led adoption model, working closely with medical professionals to ensure its devices are used effectively and responsibly. This approach not only builds trust among patients but also strengthens the brand’s credibility within the healthcare ecosystem.
With the latest funding, CURAPOD is actively expanding its footprint across India, aiming to bring accessible, technology-driven pain management solutions to a wider population.
The Future of Wearable Pain Management in India
As awareness grows around drug-free and non-invasive pain management, startups like CURAPOD are well-positioned to play a critical role in the future of healthcare. With strong investor backing, advanced technology, and a clear focus on musculoskeletal health, CURAPOD is poised to become a leading name in India’s healthtech and wearable medical device space.
Ruchi Kumar is the associate editor at Entrepreneur News Network and TVW News India, where she leads editorial strategy, brand storytelling, and startup ecosystem coverage. With a strong focus on innovation, business, and marketing insights, he curates impactful narratives that spotlight India’s evolving entrepreneurial landscape.